TY - JOUR
T1 - Bladder-sparing radiotherapy for muscle-invasive bladder cancer
T2 - a survey of providers to determine barriers and enablers
AU - Walker, Melanie
AU - French, Simon D.
AU - Doiron, R. Christopher
AU - Brennan, Kelly
AU - Feldman-Stewart, Deb
AU - Siemens, D. Robert
AU - Mackillop, William J.
AU - Booth, Christopher M.
PY - 2017/11
Y1 - 2017/11
N2 - Background To understand barriers and enablers to use of curative-intent radiotherapy (RT) for muscle-invasive bladder cancer using the Theoretical Domains Framework (TDF). Methods Canadian urologists, radiation oncologists (ROs) and medical oncologists (MOs) participated in a web-based survey to assess barriers and enablers to use of RT. Survey questions were thematically mapped to TDF domains. Logistic regression was used to identify TDF domains associated with high referral/use of RT. Results 64 urologists, 29 ROs and 26 MOs participated. Participants reported comparable survival at five years with cystectomy (51%) and RT with concurrent chemotherapy (50%). Despite this, participants reported low RT referral/treatment rates: Urologists referred a median of 2/10 patients to RO; ROs treated a median of 5/10 patients referred; and MOs referred a median of 2/8 patients not referred to RO by urology. Among urologists, the TDF domains ‘beliefs about consequences’ (OR = 8.1, 95% CI 1.5–44.9), 'social and professional role’ (OR = 11.2, 95% CI 2.3–53.6) and ‘environmental context and resources’ (OR = 5.9, 95% CI 1.5–23.3) were associated with higher rates of RO referral. Conclusions We have identified factors associated with referral for RT among patients with bladder cancer. These factors should be addressed as part of a concerted effort to increase utilization of RT.
AB - Background To understand barriers and enablers to use of curative-intent radiotherapy (RT) for muscle-invasive bladder cancer using the Theoretical Domains Framework (TDF). Methods Canadian urologists, radiation oncologists (ROs) and medical oncologists (MOs) participated in a web-based survey to assess barriers and enablers to use of RT. Survey questions were thematically mapped to TDF domains. Logistic regression was used to identify TDF domains associated with high referral/use of RT. Results 64 urologists, 29 ROs and 26 MOs participated. Participants reported comparable survival at five years with cystectomy (51%) and RT with concurrent chemotherapy (50%). Despite this, participants reported low RT referral/treatment rates: Urologists referred a median of 2/10 patients to RO; ROs treated a median of 5/10 patients referred; and MOs referred a median of 2/8 patients not referred to RO by urology. Among urologists, the TDF domains ‘beliefs about consequences’ (OR = 8.1, 95% CI 1.5–44.9), 'social and professional role’ (OR = 11.2, 95% CI 2.3–53.6) and ‘environmental context and resources’ (OR = 5.9, 95% CI 1.5–23.3) were associated with higher rates of RO referral. Conclusions We have identified factors associated with referral for RT among patients with bladder cancer. These factors should be addressed as part of a concerted effort to increase utilization of RT.
KW - bladder cancer
KW - radiotherapy
KW - cystectomy
KW - knowledge translation
KW - quality of care
UR - http://www.scopus.com/inward/record.url?scp=85030160094&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2017.08.036
DO - 10.1016/j.radonc.2017.08.036
M3 - Article
C2 - 28974310
AN - SCOPUS:85030160094
SN - 0167-8140
VL - 125
SP - 351
EP - 356
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 2
ER -